Gregory Hayes bought $1.0M of Becton, Dickinson and (BDX)
Executed Aug 11 2025, disclosed Aug 11 2025, the same day.
Over the 21 trading sessions from the disclosed entry session (Aug 11 2025), the stock returned -1.0% (delay-adjusted); from the execution session (Aug 11 2025), -1.0%. Derived: entry at the session's open, exit at the close 20 sessions later.
Gregory Hayes (Executive Chairman) filed 3 Form 4 reports in the past 24 months (2 purchases, 1 sale), most often in Becton, Dickinson and Company (BDX). Across 2 priced purchase filings, the average 21-session return was +4.0% from execution and +4.0% from disclosure (delay-adjusted; derived). The largest single filing was $12.7M of RTX (101,668 sh across 2 lots, as filed), executed Feb 19 2025.
Healthcare · Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products fo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→